Nanoformulation Strategies for Cancer Treatment 2021
DOI: 10.1016/b978-0-12-821095-6.00001-x
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine for combinational anticancer drug therapeutics: Recent advances, challenges, and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 88 publications
0
1
0
Order By: Relevance
“…Relative to cisplatin, it significantly suppresses the proliferation of A549 lung cancer cells. This is probably due to stimulation of p53 protein and initiation of apoptosis [ 84 ].…”
Section: Nanocarriers Of Platinum and Palladium Complexesmentioning
confidence: 99%
“…Relative to cisplatin, it significantly suppresses the proliferation of A549 lung cancer cells. This is probably due to stimulation of p53 protein and initiation of apoptosis [ 84 ].…”
Section: Nanocarriers Of Platinum and Palladium Complexesmentioning
confidence: 99%